Mo. Code Regs. Ann. tit. 19, § 30-1.002
PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.
(1) Schedules of Controlled Substances.
(A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.
or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
XX. Proheptazine YY. Properidine ZZ. Propiram AAA. Racemoramide BBB. Thiofentany (N-phenyl-N- (1-(2-thienyl)ethyl-4- piperidinyl)- propanamide
ly excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and
9634 salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)3. of this rule only, the term isomer includes the optical, position and geometric isomers.):
Some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;
Some trade or other names: 4-bromo-2, 5- dimethoxy-a-methylphenethylamine; 4-bromo- 2, 5-DMA;
Some trade or other names: 2,5-dimethoxyamethylphenethylamine; 2,5-DMA; 19 CSR 30-1
Some trade or other names: DOET F. 2,5-dimethoxy-4-(n)- propylthiophenethylamine (other name: 2C-T-7) G. 2-(2,5-Dimethoxy-4-(n)- propylphenyl) ethanamine (2C-P) H. 2-(2,5-Dimethoxy-4- ethylphenyl) ethanamine (2C-E ) I. 2-(2,5-Dimethoxy-4- methylphenyl) ethanamine (2C-D) J. 2-(2,5-Dimethoxy-4-nitrophenyl) ethanamine (2C-N) K. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) L. 2-(4-Chloro-2,5- dimethoxyphenyl) ethanamine (2C-C) M. 2-(4-Ethylthio-2,5- dimethoxyphenyl) ethanamine (2C-T-2) N. 2-(4-Iodo-2,5- dimethoxyphenyl) ethanamine (2C-I) O. 2-(4-Isopropylthio)-2,5- dimethoxyphenyl) ethanamine (2C-T-4) P. 4-methoxyamphetamine Some trade or other names: 4-methoxyamethylphenethylamine; paramethoxyamphetamine; PMA; Q. 5-methoxy-3,4- methylenedioxyamphetamine 7401 R. 4-methyl-2,5- dimethoxyamphetamine Some trade and other names: 4-methyl-2, 5- dimethoxy-a-methylphenethylamine; DOM; and STP; S. 3,4- methylenedioxyamphetamine 7400 T. 3,4-methylenedioxymethamphetamine(MDMA) U. 3,4-methylenedioxy-N- ethylamphetamine (also known as N-ethylalphamethyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA,MDE and MDEA) V. N-hydroxy-3,4- methylenedioxyamphetamine (also known as N-hydroxyalpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA) W. 3,4,5- trimethoxyamphetamine X. 5-MeO-DMT or 5-methoxy- N,N-dimethyltryptamine Y. Alpha-methyltryptamine Z. Bufotenine Some trade and other names: 3-(b-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine;mappine; 7348 AA. Diethyltryptamine 7434 Some trade and other names: N, N-Diethyltryptamine; DET; 7524 BB. Dimethyltryptamine Some trade or other names: DMT; 7435
7508 Some trade and other names: 7-Ethyl- 6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6, 7521 9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole; Tabernanthe iboga; 7517 EE. Lysergic acid diethylamide 7315 FF. Marihuana 7360 Some trade or other names: marijuana; GG. Mescaline 7381 HH. Parahexyl 7374 Some trade or other names: 3-Hexyl-1- hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;
Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture or preparation of such plant, its seeds or extracts; JJ. N-ethyl-3-piperidyl benzilate 7482 KK. N-methyl-3-piperidyl benzilate 7484
contained in a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
nol and their optical isomers;
cannabinol and their optical isomers;
cannabinol and its optical isomers; and
substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered. OO. Ethylamine analog of phencyclidine 7455 Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl)-ethylamine, cyclohexamine, PCE; PP. Pyrrolidine analog of phencyclidine
Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP; QQ. Thiophene analog of phencyclidine Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP; RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine Some other names: TCPy. SS. Salvia divinorum TT. Salvinorin A UU. Synthetic cannabinoids: Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
derived from 3-(1-naphthoyl)indole or 1H- indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:
fluoropentyl)-3- (1-naphthoyl)indole 7201
pentyl-2-methyl- 3-(1-naphthoyl)indole
2-methyl-3-(1- naphthoyl)indole
3-(1-naphthoyl)indole 7118
3-(1-naphthoyl)indole 7019
3-(1-naphthoyl)indole 7173
3-(4-methoxy-1- naphthoyl)indole 7081
2-methyl-3-(4- methoxy-1- naphthoyl)indole
3-(4-methyl-1- naphthoyl)indole 7122
3-(7-methoxy-1- naphthoyl)indole
derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;
derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;
derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:
JOHN R. ASHCROFT
(morpholinyl)ethyl))-3- (1-naphthoyl)indole 7200
3-(4-ethyl-1- naphthoyl)indole
3-(4-chloro-1- naphthoyl)indole 7398
3-(4- methoxyphenylacetyl)indole
3-(2- chlorophenylacetyl)indole
3-(2- methoxyphenylacetyl)indole
3-(2- methylphenylacetyl)indole
cyclohexylethyl)-3-(2- methoxyphenylacetyl)indole
or 2-[(1R,3S)-3- hydroxycyclohexyl]-5-(2- methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n- 4,6, or 7; 7297, 7298
(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3- [ ( 2 R ) - 5 - p h e n y l p e n t a n - 2 - y l ] o x y - 5,6,6a,7,8,9,10,10a-octahydrophenanthridin- 1-yl] acetate (VIII) HU-210, or (6aR,10aR)-9- (hydroxymethyl)-6,6-dimethyl-3-(2-methyl o c t a n - 2 - y l ) - 6 a , 7 , 1 0 , 1 0 a - tetrahydrobenzo[c]chromen-1-ol
Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate; 2010
excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
Some trade or other names: aminoxaphen; 2- amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- phenyl-2-oxazolamine; 19 CSR 30-1
Some trade or other names: 2-(methylamino)- propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1- one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinine; AL-464; AL-422; AL-463 and URI 432;
(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alphatrimethylphenethylamine)
subject to emergency scheduling under federal law shall include any material, compound, mixture or preparation which contains any quantity of the following substances: AND SENIOR SERVICES
P. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl-1H- indazole-3-carboxamide, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: AB-PINACA) 7023
presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed or extracts. 7032
(B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.
chemical synthesis. Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:
compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:
preparation thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;
compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:
extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or
crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy)
or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:
B. Alphaprodine
9600 K. Levo-alphacetylmethadol 9610 Some other names: 9620 methadol, levomethadyl acetate, 9639 LAAM 9640 L. Levomethorphan 9630 M. Levorphanol 9050 N. Metazocine 9334 O. Methadone 9190 P. Methadone-Intermediate,
9150 Q. Moramide-Intermediate, 2-
9143 R. Pethidine (Meperidine) 9652 S. Pethidine-Intermediate-A, 4-
9650 W. Piminodine
ed or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
excepted or unless listed in another schedule, any material, compound, mixture, or prepa-
9737 ration which contains any quantity of the fol- 9010 lowing substances having a depressant effect (Non-dosage Forms)
levo-alphaacetyl-
4-cyano-2-dimethylamino- 4,4-diphenyl butane
methyl-3-morpholino-1,1- diphenylpropane-carboxylic acid
cyano-1-methyl-4- phenylpiperidine
ethyl-4-phenylpiperidine-4- carboxylate
methyl-4-phenylpiperidine- 4-carboxylic acid
optical isomers, and salts of its optical isomers
isomers, and salts of its isomers
isomers, and salts of its isomers 9020 on the central nervous system, including its 9800 salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts 9273 of isomers is possible within the specific 9743 chemical designation:
9648 Another name for nabilone: (±)trans-3-(1, 1- 9210 dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 9220 1-hydroxy-6, 6-dimethyl-9H-dibenzo(b,d) 9240 pyran-9-one. 9250 6. Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, 9254 or preparation which contains any quantity of the following substances:
amphetamine and methamphetamine:
9230 Some trade or other names: phenyl-2- propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;
dine (PCP):
9732 7. Any material, compound, mixture, or 9733 preparation which contains any quantity of 9739 the following alkyl nitrites:
9729 (C) Schedule III shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
excepted or unless listed in another schedule,
1100 any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect 1205 on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers when- 1105 ever the existence of such salts, isomers, and salts of isomers is possible within the specif- 1724 ic chemical designation:
preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted 19 CSR 30-1
A. Immediate precursor
B. Immediate precursors to phencycli-
C. Immediate precursor to fentanyl:
compounds under section 308.32 and any other drug of the quantitive composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances
excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
ration containing:
or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;
taining:
or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository;
quantity of a derivative of barbituric acid or any salt thereof
gamma hydroxybutyric acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;
Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2-thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4- ( 2 - f l u o ro p h e ny l ) - 6 - 8 - d i hyd ro - 1 , 3 , 8 - trimethylpyrazolo-(3,4-e) (1,4)-diazepin- 7(1H)-one, flupyrazapon.
1405 4. Narcotics drugs. Unless specifically 1228 excepted or unless listed in another schedule, 1645 any material, compound, mixture, or prepa- 1647 ration containing limited quantities of any of 1615 the following narcotic drugs or any salts thereof:
codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium
2126 codeine per one hundred milliliters (100 mL) 2316 or not more than ninety milligrams (90 mg) 2271 per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts
drocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90
2126 mg) per dosage unit, with one (1) or more 2316 active, nonnarcotic ingredients in recognized 2271 therapeutic amounts
milligrams (300 mg) of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active,
2100 nonnarcotic ingredients in recognized ther- 2510 apeutic amounts 2020 E. Not more than five hundred milligrams (500 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 g) or not more than twenty-five milligrams (25 mg) per dosage unit, with one
2012 recognized therapeutic amounts
mg) of morphine per one hundred milliliters (100 mL) or per one hundred grams (100 g), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic
7285 amounts 7300 5. Any material, compound, mixture, or 7310 preparation containing any of the following 2575 narcotic drugs or their salts, as set forth below:
2261 6. Anabolic steroids. Unless specially 2600 excepted or unless listed in another schedule, 2605 any material, compound, mixture, or prepa- 2610 ration containing any quantity of the following substances, including its salts, isomers, 7295 and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation. DEA has assigned code 4000 for all anabolic steroids. Anabolic steroids. Any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that promotes muscle 9400 growth, except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this subdivision. Unless specifically excepted or unless listed in another schedule, any materi- 9803 al, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers:
droxy-5α-androst-1-ene)
droxy-5α-androst-1-ene)
droxy-androst-4-ene)
droxy-androst-5-ene)
1-en-3,17-dione)
3,17-dione)
9808 3,17-dione)
17β-hydroxyandrost-4-en-3-one)
1,4,-diene-3-one)
3,17-dione)
β-hydroxyandrost-4-en-3-one)
yandrost-4-en-3-one)
(4-chloro-17β-hydroxy-17α-methyl-androst-
9810 1,4-dien-3-one)
methyl-5α-androst-2-en-17β-ol) madol)
9064 drotestosterone) (s) 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)
methyl-5α-androstan-3-one)
hydroxyestr-4-ene)
methyl-11 β,17β-dihydroxyandrost-4-en-3- one)
formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)
V. Formebulone (Formebolone) (2-
hydroxyandrostano[2,3-c]-furazan)
one
droxy-androst-4-en-3-one)
(4,17β-dihydroxy-estr-4-en-3-one) AA. Mestanolone (17α-methyl-17β- hydroxy-5α-androstan-3-one) BB. Mesterolone(1α-methyl-17β- hydroxy-[5α]-androstan-3-one)
hydroxyandrost-1,4-dien-3-one)
3β,17β-dihydroxyandrost-5-ene) EE. Methasterone (2α,17α-dimethyl- 5α-androstan-17β-ol-3-one) FF. Methenolone (1-methyl-17β- hydroxy-5α-androst-1-en-3-one) GG. 17α-methyl-3 β,17β-dihydroxy- 5α-androstane) HH. 17α-methyl-3α,17β-dihydroxy- 5α-androstane)
drost-4-ene JJ. 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4- en-3-one) KK. Methyldienolone (17α-methyl- 17β-hydroxyestra-4,9(10)-dien-3-one)
17β-hydroxyestra-4,9,11-trien-3-one)
methyl-17β-hydroxyandrost-4-en-3-one) NN. Mibolerone (7α,17α-dimethyl- 17β-hydroxyestr-4-en-3-one) OO. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst- 1-en-3-one) (a.k.a. 17-α-methyl-1-testosterone) PP. Nandrolone (17β-hydroxyestr-4- ene-3-one) Q Q . 1 9 - n o r - 4 - a n d r o s t e n e d i o l (3β,17β-dihydroxyestr-4-ene) R R . 1 9 - n o r - 4 - a n d r o s t e n e d i o l (3α,17β-dihydroxyestr-4-ene) SS. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) TT. 19-nor-5-androstenediol (3β,17β- dihydroxyestr-5-ene) U U . 1 9 - n o r - 5 - a n d r o s t e n e d i o l (3α,17β-dihydroxyestr-5-ene)
4-en-3,17-dione) WW. 19-nor-5-androstenedione (estr- 5-en-3,17-dione)
17β-hydroxygon-4-en-3-one) YY. Norclostebol (4-chloro-17β- hydroxyestr-4-en-3-one) ZZ. Norethandrolone (17α-ethyl-17β- hydroxyestr-4-en-3-one) AAA. Normethandrolone (17α- methyl-17β-hydroxyestr-4-en-3-one) BBB. Oxandrolone (17α-methyl-17β- hydroxy-2-oxa-[5α]-androstan-3-one)
4,17β-dihydroxyandrost-4-en-3-one)
hyd rox y m e t hy l e n e - 1 7 β - hyd rox y - [ 5 α ] - androstan-3-one) EEE. Prostanozol (17β-hydroxy-5α- androstano[3,2-c]pyrazole) FFF. Stanolone (Δ1-dihydrotestosterone (a.k.a. 1-testosterone)(17β-hydroxy- 5α-androst-1-en-3-one)) GGG. Stanozolol (17α-methyl-17β- hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole) HHH. Stenbolone (17β-hydroxy-2- methyl-[5α]-androst-1-en-3-one)
13,17-secoandrosta-1,4-dien-17-oic acid lactone) JJJ. Testosterone(17β-hydroxyandrost-4-en-3-one); K K K . Te t r a h y d r o g e s t r i n o n e (13β,17α-diethyl-17β-hydroxygon-4,9, 11- trien-3-one)
4,9,11-trien-3-one)
drug or substance described or listed in this subparagraph, if that salt, ester, or isomer promotes muscle growth except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the secretary of Health and Human Services for that administration.
oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369 (Some other names for dronabinol: (6aRtrans)- 6a,7,8,10a-tetrahydro-6.6.9- trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1- ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)
(D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:
mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit 9167
4-dimethylamino-1,2-diphenyl-3-methyl-2- propionoxybutane)
methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol)
cotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 g);
milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 g); or
milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 g).
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
AA. Haloxazolam BB. Ketazolam CC. Loprazolam DD. Lorazepam EE. Lormetazepam FF. Mebutamate GG. Medazepam HH. Meprobamate II. Methohexital JJ. Methylphenobarbital (Mephobarbital) KK. Midazolam LL. Nimetazepam MM. Nitrazepam NN. Nordiazepam OO. Oxazepam PP. Oxazolam QQ. Paraldehyde RR. Petrichloral SS. Phenobarbital TT. Pinazepam UU. Prazepam VV. Quazepam WW. Suvorexant XX. Temazepam YY. Tetrazepam ZZ. Triazolam AAA. Zaleplon BBB. Zolpidem CCC. Zopiclone
pound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:
mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
2771 L. SPA (-)-1-dimethylamino-
2773 6. Other substances. Unless specifically 2885 excepted or unless listed in another schedule, 2774 any material, compound, mixture, or prepa- 2800 ration which contains any quantity of the fol- 2836 lowing substances, including its salts: 2820 A. Pentazocine 2264 B. Butorphanol (including its
2250 C. Eluxadoline (5-[[[(2S)-2-
2883 7. Ephedrine. Any material, compound, 2764 mixture, or preparation which contains any 2881 quantity of the following substances having a 2223 stimulant effect on the central nervous system 2925 including their salts, isomers, and salts of iso- 2886 mers: 2887 A. Ephedrine or its salts, optical iso- 2781 mers, or salts of optical isomers as the only 2783 active medicinal 2784 ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.
1670 this subsection.
active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall
1625 include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred
1230 grams (100 g); 1610 B. Not more than one hundred mil- 1760 ligrams (100 mg) of dihydrocodeine per one 1575 hundred milliliters (100 mL) or per one hun- 1605 dred grams (100 g); 1580 C. Not more than one hundred mil- 1680 ligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 g). 1530 D. Not more than two and five-tenths 1640 milligrams (2.5 mg) of diphenoxylate and not 1750 less than twenty-five micrograms (25 mcg) of 1675 atropine sulfate per dosage unit. 1,2-diphenylethane 1635
optical isomers) 9720
amino-3-[4-aminocarbonyl)- 2,6-dimethylphenyl]-1- oxopropyl] [(1S)-1-(4-phenyl- 1 H-imidazol-2- yl)ethyl]amino]methyl]-2- methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers 9725
ingredient or contains
ligrams (100 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 g).
ligram (0.5 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit.
exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including its salts, isomers, and salts of isomers:
tion containing any detectable quantity of pseudoephedrine or its salts or optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starchbased solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:
prescription in order to be dispensed.
excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:
Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs
AUTHORITY: sections 195.015 and 195.195, RSMo 2016.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. *Original authority: 195.015, RSMo 1971, amended 1989, 2014 and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014.